The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on October 22, 2026

5 hours ago

RAPIDÉ Brings Cold Immersion, Sauna and Recovery Technologies Together

Indeterminate EIN Presswire

an hour ago

The Joint Corp. to Report 2026 Third Quarter Results on Thursday, November 5 and Host Conference Call and Webcast

Indeterminate GlobeNewswire

an hour ago

Blue Point Brewing Co.’s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews

Indeterminate GlobeNewswire

an hour ago

Newron Completes Enrollment of Pivotal Phase 3 ENIGMA-TRS 1 Study

Indeterminate GlobeNewswire

an hour ago

BPGbio Appoints Jason Krause as Senior Vice President and General Counsel

Indeterminate GlobeNewswire

an hour ago

Apollo Therapeutics Announces Science Translational Medicine Publication Supporting APL-9796 as a Potential Disease-Modifying Approach for Pulmonary Hypertension

Indeterminate GlobeNewswire

an hour ago

Generate Biomedicines to Participate in November Investor Conferences

Indeterminate GlobeNewswire

an hour ago

Sundance Biosciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of SUN-627 for Progressive Forms of Multiple Sclerosis (MS)

Indeterminate GlobeNewswire

an hour ago

Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4

Indeterminate GlobeNewswire

an hour ago

BlossomHill Therapeutics Announces Collaboration with Foundation Medicine to Develop First Companion Diagnostic for BH-30643 in EGFR C797S Mutated Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

an hour ago

Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

Indeterminate GlobeNewswire

an hour ago

Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

an hour ago

Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne

Indeterminate GlobeNewswire

an hour ago

Medicenna to Present Preclinical Data on Its CD122 Superantagonist MDNA209 at The Promises of Treg and Interleukin-2 Therapies Conference

Indeterminate GlobeNewswire

an hour ago

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs

Indeterminate GlobeNewswire

2 hours ago

BioNTech treibt klinische Phase-3-Studie zu Pumitamig mit Gileads gegen TROP2-gerichtetem Antikörper-Wirkstoff-Konjugat Sacituzumab Govitecan bei Dreifach-Negativem Brustkrebs voran

Indeterminate GlobeNewswire

2 hours ago

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

2 hours ago

Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire

2 hours ago

Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

2 hours ago

Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies

Indeterminate GlobeNewswire